Canada Biosensors Market Size, Share, and COVID-19 Impact Analysis, By Technology (Thermal, Electrochemical, Piezoelectric, and Optical), By Application (Medical, Food Toxicity, Bioreactor, Agriculture, Environment, and Others) By End-user (Home Healthcare Diagnostics, POC Testing, Food Industry, Research Laboratories, and Security & Bio-Defense), and Canada Biosensors Market Insights, Industry Trend, Forecasts to 2033
Industry: HealthcareCanada Biosensors Market Insights Forecasts to 2033
- The Canada Biosensors Market Size was valued at USD 2.15 Billion in 2023.
- The Market is Growing at a CAGR of 7.78% from 2023 to 2033
- The Canada Biosensors Market Size is Expected to reach USD 4.55 Billion by 2033
Get more details on this report -
The Canada Biosensors Market Size is anticipated to Exceed USD 4.55 Billion by 2033, Growing at a CAGR of 7.78% from 2023 to 2033. The increasing burden of chronic diseases, technological advancements, and increasing demand for point-of-care (POC) testing are driving the growth of the biosensors market in the Canada.
Market Overview
Biosensors are analytical devices that are used for environmental monitoring, disease detection, food safety, defense, drug discovery, and other applications. These devices are composed of biologically sensing elements such as enzymes, microorganisms, and antibiotics which are combined with a physiological transducer (optical and electrochemical) for providing signals by binding or interacting with the analyte. By precisely identifying and screening lead drug compounds, the use of biosensing technologies in diverse drug discovery operations is anticipated to improve the entire research and development process. The market participants are aggressively creating these cutting-edge technologies to speed up drug discovery and development, motivated by the advantages of biosensors. Further, the surging development of wearable biosensors for human health monitoring and personalized medicine is offering market opportunities for biosensors.
Report Coverage
This research report categorizes the market for the Canada biosensors market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada biosensors market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada biosensors market.
Canada Biosensors Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 2.15 Billion |
Forecast Period: | 2023-2033 |
Forecast Period CAGR 2023-2033 : | 7.78% |
2033 Value Projection: | USD 4.55 Billion |
Historical Data for: | 2019-2022 |
No. of Pages: | 210 |
Tables, Charts & Figures: | 101 |
Segments covered: | By Technology, By Application, By End-user and COVID-19 Impact Analysis. |
Companies covered:: | Nova Biomedical Corporation, Bio-Rad International, Nicoya Lifesciences, Biosensors International, Medtronic, Nix Biosensors, Abbott Laboratories, Siemens Healthcare, and other key vendors. |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
Biosensors are increasingly used for monitoring health metrics at home or in near-patient settings, thereby reducing the need for invasive treatments or frequent hospital visits. The increasing cases of chronic diseases in the country surge the need for biosensors for long-term treatment of these diseases, thereby driving the market demand. The emerging trend in biosensors includes DNA microarrays, microfluidics, synthetic gene construct, smart cell culture systems, and 3D bioprinting which is propelling the market growth. The electrochemical and optical biosensors-based POCT are used for detecting disease biomarkers. The development of biomarker-detecting POC biosensors is driving the market growth.
Restraining Factors
The stringent regulatory requirements for the approval of biosensor devices are challenging the Canada biosensors market.
Market Segmentation
The Canada Biosensors Market share is classified into technology, application, and end-user.
- The electrochemical segment dominated the market with the largest market share in 2023.
The Canada biosensors market is segmented by technology into thermal, electrochemical, piezoelectric, and optical. Among these, the electrochemical segment dominated the market with the largest market share in 2023. Electrochemical biosensors are effectively used to analyze the content of a biological sample due to the direct conversion of a biological event to an electronic signal. The ease of use, rapid results, portability, and widespread application in medical and non-medical sectors are contributing to driving the market in the electrochemical segment.
- The medical segment accounted for the largest market share during the forecast period.
The Canada biosensors market is segmented by application into medical, food toxicity, bioreactor, agriculture, environment, and others. Among these, the medical segment accounted for the largest market share during the forecast period. Biosensors are employed in medical research and testing to quickly and precisely detect illnesses and deliver substantial healthcare. In cancer research, electrochemical biosensors are used to identify biomarkers with speed and accuracy. The advancement in biosensors in the medical field is driving the market growth.
- The POC testing segment dominated the Canada biosensors market with the largest market share in 2023.
Based on the end-user, the Canada biosensors market is divided into home healthcare diagnostics, POC testing, food industry, research laboratories, and security & bio-defense. Among these, the POC testing segment dominated the Canada biosensors market with the largest market share in 2023. Technological developments that produce novel products, such ultra-sensitive printable biosensors for PoC applications aid in the detection or monitoring of organic fluids like urine, saliva, blood, and sweat. The increasing need for diagnostic tools with enhanced features including sensitivity, selectivity, and low response time is driving the market growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada biosensors market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Nova Biomedical Corporation
- Bio-Rad International
- Nicoya Lifesciences
- Biosensors International
- Medtronic
- Nix Biosensors
- Abbott Laboratories
- Siemens Healthcare
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Canada, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Canada Biosensors Market based on the below-mentioned segments:
Canada Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
Canada Biosensors Market, By Application
- Medical
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
Canada Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security & Bio-Defense
Need help to buy this report?